Suppr超能文献

l-天冬酰胺酶的催化机制。

Mechanism of Catalysis by l-Asparaginase.

机构信息

Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.

Department of Physics, The University of Vermont, Burlington, Vermont 05408, United States.

出版信息

Biochemistry. 2020 May 26;59(20):1927-1945. doi: 10.1021/acs.biochem.0c00116. Epub 2020 May 11.

Abstract

Two bacterial type II l-asparaginases, from and , have played a critical role for more than 40 years as therapeutic agents against juvenile leukemias and lymphomas. Despite a long history of successful pharmacological applications and the apparent simplicity of the catalytic reaction, controversies still exist regarding major steps of the mechanism. In this report, we provide a detailed description of the reaction catalyzed by type II l-asparaginase (EcAII). Our model was developed on the basis of new structural and biochemical experiments combined with previously published data. The proposed mechanism is supported by quantum chemistry calculations based on density functional theory. We provide strong evidence that EcAII catalyzes the reaction according to the double-displacement (ping-pong) mechanism, with formation of a covalent intermediate. Several steps of catalysis by EcAII are unique when compared to reactions catalyzed by other known hydrolytic enzymes. Here, the reaction is initiated by a weak nucleophile, threonine, without direct assistance of a general base, although a distant general base is identified. Furthermore, tetrahedral intermediates formed during the catalytic process are stabilized by a never previously described motif. Although the scheme of the catalytic mechanism was developed only on the basis of data obtained from EcAII and its variants, this novel mechanism of enzymatic hydrolysis could potentially apply to most (and possibly all) l-asparaginases.

摘要

两种细菌 II 型 l-天冬酰胺酶,来自 和 ,作为治疗儿童白血病和淋巴瘤的药物已经发挥了 40 多年的关键作用。尽管在药理学应用方面有着悠久的成功历史,且催化反应的过程看似简单,但在其机制的主要步骤上仍然存在争议。在本报告中,我们详细描述了 II 型 l-天冬酰胺酶(EcAII)催化的反应。我们的模型是基于新的结构和生化实验以及先前发表的数据建立的。所提出的机制得到了基于密度泛函理论的量子化学计算的支持。我们提供了强有力的证据表明,EcAII 按照双取代(乒乓)机制催化反应,形成共价中间体。与其他已知水解酶催化的反应相比,EcAII 的催化有几个独特的步骤。在这里,反应是由弱亲核试剂苏氨酸引发的,没有直接的通用碱辅助,尽管鉴定出了一个远程通用碱。此外,在催化过程中形成的四面体中间体通过从未有过描述的基序稳定。尽管催化机制的方案仅基于从 EcAII 及其变体获得的数据开发,但这种新的酶水解机制可能适用于大多数(可能是所有)l-天冬酰胺酶。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验